Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

BACKGROUND: Synapse loss is an early event that precedes neuronal death and symptom onset and is considered the best neuropathological correlate of cognitive decline in Alzheimer’s disease (AD). Vesicle-associated membrane protein 2 (VAMP-2) has emerged as a promising biomarker of AD-related synapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Goossens, Julie, Cervantes González, Alba, Dewit, Nele, Lidón, Laia, Fortea, Juan, Alcolea, Daniel, Lleó, Alberto, Belbin, Olivia, Vanmechelen, Eugeen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612328/
https://www.ncbi.nlm.nih.gov/pubmed/37898760
http://dx.doi.org/10.1186/s13195-023-01336-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612328/
https://www.ncbi.nlm.nih.gov/pubmed/37898760
http://dx.doi.org/10.1186/s13195-023-01336-0

Ejemplares similares